Trans-2-decenoic acid derivative and pharmaceutical agent containing the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 24, 2015
Grant Date -
Aug 29, 2013
app pub date -
Nov 1, 2011
filing date -
Nov 2, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
An object of the present invention is to provide a novel trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof and to provide a pharmaceutical agent which contains said compound as an active ingredient and has a highly safe neurotrophic factor-like activity or an alleviating action for side effect induced by administration of anti-cancer agents. The trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof which is the compound of the present invention is specifically represented by the formula (1):
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully